Clinical Trial Update: Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for flumatinib in chronic myeloid leukemia in the chronic phase after failure with imatinib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia Chronic Phase

Drugs mentioned

• Flumatinib (flumatinib)

Snippet

Sponsor: Shenzhen Second People's Hospital | Conditions: Flumatinib, Chronic Myeloid Leukemia, Chronic Phase | Phase 4 | Status: UNKNOWN